Davidow Robert L's Form 4 filing
Avenue Therapeutics, Inc. (ATXI) · filed Dec 13, 2023
- Accession no.
- 0001553350-23-000471
- Filed
- Dec 13, 2023, 4:02 PM ET
- Trade date
- Dec 11, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $86.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davidow Robert LCIK 0002002210 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | Common Stock | SSaleDisposed | −264,000 | $0.14F1 | −$36,960 | 681,000 | Direct | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −18,000 | $0.15 | −$2,700 | 22,000 | Indirect | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −61,000 | $0.14F1 | −$8,540 | 74,000 | Indirect | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −126,000 | $0.14F1 | −$17,640 | 215,800 | Indirect | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −128,000 | $0.14F1 | −$17,920 | 147,000 | Indirect | |
| Dec 11, 2023 | Common Stock | SSaleDisposed | −20,000 | $0.14 | −$2,800 | 80,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.13 to $0.15, inclusive. Each sale price was below the purchase prices for the shares, and the reporting person engaged in the transactions for tax purposes and to cause his holdings to fall below 10% of the outstanding shares of the issuer's common stock and thereby cease being subject to the requirements of Section 16 of the Securities Exchange Act of 1934. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
Referenced by the price of 4 transactions in Table I.